Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 19 results for "shivinder mohan singh"

The Biggest Takeaway from this Budget is Direction: Shivinder ...

| Duration: 1 min, 48 sec Reacting to the Budget, Executive Vice-Chairman of Fortis Healthcare, Shivinder Mohan Singh said that the intent of the government has been made very clear. Featured More More NDTV, 1 month ago

2 images for "shivinder mohan singh"

Forbes India, 1 month ago
Livemint.com, 2 months ago
Deccan Chronicle

Sun Pharma shares bounce back, up by 3 per cent on bourses

Sun Pharmaceutical Industries Ltd slumped as much as 10.9 per cent Mumbai: Stocks of Sun Pharmaceutical made acomeback at the bourses today, rising nearly 3 per cent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around ...
 Deccan Chronicle6 days ago Sun Pharma shares bounce back, up nearly 2% at close  ZeeNews.com6 days ago Sun Pharma shares bounce back, up 3% on bourses  ZeeNews.com6 days ago
Financial Express

After the fall, Sun Pharma shares rebound on value buying, rise 3 pct

Japanese drug maker Daiichi Sankyo has sold its entire stake of around 9 per cent in Sun Pharmaceutical Industries for over Rs 20,420 crore, which it received after merger of Ranbaxy Laboratories in the Indian firm, ending its seven years of ...
 Financial Express6 days ago Daiichi exits Sun; garners Rs 20,025 crore from 9% stake sale  Economic Times6 days ago
DNA India

Lifeline ends for Ranbaxy after half-a-century existence

Search Ranbaxy Laboratories on the Google and the website link will take you to the Sun Pharmaceutical Industries official web page, as the Gurgaon-based Indian multinational giant has ceased to exist. There is no more official web page of Ranbaxy ...
 DNA India3 weeks ago RIP Ranbaxy  Business Today India1 month ago
NDTV Profit

Why This 54-Year-Old Company Stopped Trading Today

Trading in Ranbaxy was discontinued from Monday, putting curtains on the 54-year-old Gurgaon-based company, once India's biggest drugmaker by sales. Here are 10 facts about Ranbaxy : 1) Ranbaxy was named after Ran bir Singh and Gur bax ...
 NDTV Profit3 weeks ago Ranbaxy Delists on Completion of Merger with Sun Pharma: 10 Facts  NDTV Profit3 weeks ago

NATHEALTH announces leadership team for 2015-16 announced

Johnson & Johnson Medical MD, Sushobhan Dasgupta elected as the President of NATHEALTH NATHEALTH announced its new leadership team for the year 2015-16. Sushobhan Dasgupta, MD, Johnson & Johnson Medical India has been elected as the President of ...
 Financial Express1 month ago NATHEALTH elects Sushobhan Dasgupta as President  Business Standard2 months ago
Moneycontrol.com

Fortis promoter holding firms buy back Rs 280-crore NCDs

NEW DELHI: Two promoter holding firms of Fortis Healthcare have bought back a combined Rs 280-crore non-convertible debentures of the company that were alloted on private placement basis. "The company has bought back 2,000 secured rated listed ...
 Economic Times1 month ago Fortis Healthcare promoters plan Rs 280cr buyback of NCDs  Moneycontrol.com1 month ago
Forbes India

Budgeting high expectations: Why FM Jaitley has his task cut out

The 2015 budget has to bolster the Prime Minister's vision for India. It can remove bottlenecks in infrastructure, introduce measures to boost key sectors and facilitate ease of business Image: Vikas Khot (Clockwise from front left) ...
 Forbes India1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less